Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$1,612,200
-4.19%
Shares
Shares Volume: 30,000 Shares
Average Share Price: $53.74
INSIDER
Cheng Andrew
President and CEO (Director)
reported on Feb 11 2025
traded on Feb 10 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 686,062 |
| PURCHASES/SALES 1Y | 0 / 9 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,495,680.45 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 5 |
| PURCHASES/SALES 1Y | 1 / 54 |
| P/S VALUE RATIO | 0.242 |
| AVERAGE SALE VALUE | $734,459.25 |
| COMPANY PREVIOUS TRADES |